OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $15,000 | -94.1% | 28,391 | -80.9% | 0.00% | -91.7% |
| Q4 2015 | $255,000 | -80.5% | 148,391 | -31.4% | 0.01% | -75.5% |
| Q4 2014 | $1,311,000 | +1070.5% | 216,382 | +1147.2% | 0.05% | +716.7% |
| Q1 2014 | $112,000 | -89.5% | 17,350 | -90.9% | 0.01% | -89.5% |
| Q4 2013 | $1,068,000 | -17.8% | 189,706 | -10.6% | 0.06% | -19.7% |
| Q3 2013 | $1,300,000 | +81.8% | 212,118 | +73.1% | 0.07% | +208.7% |
| Q2 2013 | $715,000 | – | 122,558 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |